Basic Information
LncRNA/CircRNA Name | MEG3 |
Synonyms | MEG3, FP504, GTL2, LINC00023, NCRNA00023, PRO0518, PRO2160, onco-lncRNA-83, prebp1 |
Region | GRCh38_14:100779410-100861031 |
Ensemble | ENSG00000214548 |
Refseq | NR_002766 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | peptide | Recurrence |
Cancer&Entry Information
Cancer Name | glioma |
ICD-0-3 | NA |
Methods | qPCR, RNAi, Western blot, MTT assay etc. |
Sample | glioma tumors, cell lines (U251, U87 and A172) |
Expression Pattern | down-regulated |
Function Description | The levels of MEG3 expression were significantly decreased in glioma tissues compared with normal brain tissues. We found marked downregulation in high-grade glioma samples and to a lesser degree, decreased in low-grade glioma samples, as compared to normal brain tissues, which gave clues that MEG3 may be involved in the disease pathogenesis in glioma |
Pubmed ID | 26676363 |
Year | 2016 |
Title | Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas. |
External Links
Links for MEG3 | GenBank HGNC NONCODE |
Links for glioma | OMIM COSMIC |